摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-dimethyl-N-<4-(10H-10-phenothiazinyl)butyl>amine | 33326-77-1

中文名称
——
中文别名
——
英文名称
N,N-dimethyl-N-<4-(10H-10-phenothiazinyl)butyl>amine
英文别名
dimethyl-(4-phenothiazin-10-yl-butyl)-amine;Dimethyl-(4-phenothiazin-10-yl-butyl)-amin;10-(4-Dimethylaminobutyl)phenothiazine;N,N-dimethyl-4-phenothiazin-10-ylbutan-1-amine
N,N-dimethyl-N-<4-(10H-10-phenothiazinyl)butyl>amine化学式
CAS
33326-77-1
化学式
C18H22N2S
mdl
——
分子量
298.452
InChiKey
GULBNCLSXNTDGC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    195 °C(Press: 1 Torr)
  • 密度:
    1.115±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    31.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    氯甲烷N,N-dimethyl-N-<4-(10H-10-phenothiazinyl)butyl>amine 生成 <4-(phenothiazin-10-yl)butyl>trimethylammonium chloride
    参考文献:
    名称:
    US2590125
    摘要:
    公开号:
  • 作为产物:
    参考文献:
    名称:
    Design, Synthesis, and Evaluation of New Chemosensitizers in Multi-Drug-Resistant Plasmodium falciparum
    摘要:
    A series of new chemosensitizers (modulators) against chloroquine-resistant Plasmodium falciparum were designed and synthesized in an attempt to fabricate modulators with enhancing drug-resistant reversing efficacy and minimal side effects. Four aromatic amine ring systems-phenothiazine, iminodibenzyl, iminostilbene, and diphenylamine-were examined. Various tertiary amino groups including either noncyclic or cyclic aliphatic amines were introduced to explore the steric tolerance at the end of the side chain. The new compounds showed better drug-resistant reversing activity in chloroquine-resistant than in mefloquine-resistant cell lines and were generally more effective against chloroquine-resistant P. falciparum isolates from Southeast Asian (W2 and TM91C235) than those from South America (PC49 and RCS). Structure-activity relationship studies revealed that elongation of the alkyl side chain of the molecule retained the chemosensitizing activity, and analogues with four-carbon side chains showed superior activity. Furthermore, new modulators with phenothiazine ring exhibited the best chemosensitizing activity among the four different ring systems examined. Terminal amino function has limited steric tolerance as evidenced by the dramatic lose of the modulating activity, when the size of substituent at the amino group increases. The best new modulator synthesized in this study possesses all three optimized structural features, which consist of a phenothiazine ring and a pyrrolidinyl group joined by a four-carbon alkyl bridge. The fractional inhibitory concentration TIC) index of the best compound is 0.21, which is superior to that of verapamil (0.51), one of the best-known multi-drug-resistant reversing agents. Some of the analogues displayed moderate intrinsic in vitro antimalarial activity against a W-2 clone of P. falciparum.
    DOI:
    10.1021/jm010549o
点击查看最新优质反应信息

文献信息

  • One-pot synthesis of pharmacologically active diamines via rhodium-catalysed carbonylative hydroaminomethylation of heterocyclic allylic amines
    作者:Thorsten Rische、Kai-Sven Mu¨ller、Peter Eilbracht
    DOI:10.1016/s0040-4020(99)00536-0
    日期:1999.8
    Pharmacologically active derivatives of phenothiazine, iminodibenzyl, carbazole and pyrazole are prepared with high yields and chemoselectivity by the reaction of the correspondingN-allylic orN-methallylic compounds, primary or secondary amines, carbon monoxide and hydrogen in the presence of [Rh(cod)Cl]2 as catalyst via a one pot hydroformylation - amine condensation - reduction sequence.Figure options
    吩噻嗪,亚氨基二苄基,咔唑和吡唑的药理活性衍生物是通过使相应的N-烯丙基或N-甲基烯丙基化合物,伯或仲胺,一氧化碳和氢在[Rh(cod)Cl通过一锅加氢甲酰化-胺缩合-还原顺序得到作为催化剂的] 2。图选项
  • Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
    申请人:——
    公开号:US20030032801A1
    公开(公告)日:2003-02-13
    A compound having the structural formula 1 or a pharmaceutically acceptable salt or prodrug thereof, wherein X is a substituted or unsubstituted alkyl or a heteroatom; n is 4, 5 or 6; Y is a substituted or unsubstituted alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or 2 wherein R 1 and R 2 are each independently, H, a heteroatom, substituted or unsubstituted alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; and wherein each ring structure are independently substituted or unsubstituted is disclosed. Also disclosed are chemosensitizing agents and methods of modulating, attenuating, reversing, or affecting a cell's or organism's resistance to a given drug such as an antimalarial.
    一种具有结构式1的化合物,或其药物可接受的盐或前药,其中X是取代或未取代的烷基或杂原子; n为4、5或6; Y是取代或未取代的烷基、环烷基、杂环烷基、芳基、杂芳基或2,其中R1和R2各自独立地为H、杂原子、取代或未取代的烷基、环烷基、杂环烷基、芳基或杂芳基;并且每个环结构都是独立取代或未取代的。还公开了化学增敏剂和调节、减弱、逆转或影响细胞或生物对给定药物(如抗疟药)的耐药性的方法。
  • US6800618B2
    申请人:——
    公开号:US6800618B2
    公开(公告)日:2004-10-05
  • [EN] CHEMOSENSITIZING AGENTS AGAINST CHLOROQUINE RESISTANT PLASMODIUM FALCIPARUM AND METHODS OF MAKING AND USING THEREOF<br/>[FR] AGENTS DE CHIMIOSENSIBILISATION CONTRE PLASMODIUM FALCIPARUM RESISTANT A LA CHLOROQUINE ET LEURS PROCEDES D'UTILISATION
    申请人:US ARMY MEDICAL RES AND MATERI
    公开号:WO2002089810A1
    公开(公告)日:2002-11-14
    A compound having the structural formula or a pharmaceutically acceptable salt or prodrug thereof, wherein X is a substituted or unsubstituted alkyl or a heteroatom; n is 4,5 or 6; Y is a substituted or unsubstituted alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or wherein R1 and R2 are each independently, H, a heteroatom, substituted or unsubstituted alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; and wherein each ring structure are independently substituted or unsubstituted is disclosed. Also disclosed are chemosensitizing agents and methods of modulating, attenuating, reversing, or affecting a cell's or organism's resistance to a given drug such as an antimalarial.
  • US2590125
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多